Vir Biotechnology (VIR) Net Margin Growth (3y) (2021 - 2026)
Vir Biotechnology (VIR) Net Margin Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 9,283.00 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 506.00 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -569.00 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 4,144.00 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Vir Biotechnology | 1.28 Bn | 1.28 Bn | - | -43.32 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -43.32 Mn |
| Dec 31, 2025 | 13,864.00 |
| Sep 30, 2025 | -6.80 Mn |
| Jun 30, 2025 | -895,160.00 |
| Mar 31, 2025 | -403,169.00 |
| Dec 31, 2024 | -90,986.00 |
| Sep 30, 2024 | -908,628.00 |
| Jun 30, 2024 | -453,683.00 |
| Mar 31, 2024 | 842,187.00 |
| Dec 31, 2023 | 604,127.00 |
| Sep 30, 2023 | -180,380.00 |
| Jun 30, 2023 | -505,773.00 |
| Mar 31, 2023 | 112,702.00 |
| Dec 31, 2022 | -785,390.00 |
| Sep 30, 2022 | 349,043.00 |
| Jun 30, 2022 | 146,918.00 |
| Mar 31, 2022 | 82,520.00 |
| Dec 31, 2021 | 71,811.00 |
| Sep 30, 2021 | 126,623.00 |